Abcentra LLC, a clinical-stage biopharmaceutical company, has named Timothy Wright, MD as its new director, it was reported on Wednesday.
Wright is the general partner at Time Bioventures and is a rheumatologist and drug developer. He has served in various senior leadership roles in research and development at Pfizer, Novartis, California Institute for Biomedical Research (Calibr/Scripps Research), and Regulus Therapeutics. He has served as chief of Rheumatology at the University of Pittsburgh.
Wright completed his MD, post-doctoral clinical, and research training at Johns Hopkins.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits